Contact

Formulation & Technologies For Solid Dosage Forms

API/FDF Drug Development >> Formulation Development >> Granule / Pellets

Glatt offers expertise is in the development and manufacture of solid dosage forms with particular experience in multiparticulate systems, such as pellets and micropellets, which are further processed into final pharmaceutical dosage form.

Contact

Improvement of Bioavailability

API/FDF Drug Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement

Glatt can optimize the active substance release and bioavailability by specific optimized formulation and process methods depending on the physico-chemical property of the active substance.

Contact

Controlled Drug Release Technology

API/FDF Drug Development >> Formulation Development >> Controlled / Immediate / Modified Release

Glatt can assist you in the formulation and process development to achieve an individual adaptation of the dissolution profile based on the specific drug. We offer fast drug release, modified & delayed release, targeted drug delivery and pulsatile drug re

Contact

Taste Masking By Micro-Pelletizing of APIs

API/FDF Drug Development >> Preformulation & Material Science >> Taste Masking

Glatt has many years of experience and expertise in the taste masking of APIs. With our technologies and formulation approaches, we are able to achieve effective taste masking of drugs. A proven approach is the micro-pelletizing of APIs with the subsequen

Contact

Micropx™- Micro Pelletizing Technology

API/FDF Drug Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement

The Glatt MicroPX™ technology (micro pelletizing technology) is a continuous fluidized bed agglomeration procedure for the manufacture of pellets and micropellets with a very high active ingredient content.

Contact

Complex Perfect Spheres Technology

API/FDF Drug Development >> Formulation Development >> Granule / Pellets

The Glatt CPS™ technology (Complex Perfect Spheres Technology) is a further development of the rotor fluidized bed process. It allows for the manufacture of functionalized pellets and micropellets with perfect roundness and surface.

Contact

FDA & EU-GMP Approved Formulation Development

API/FDF Drug Development >> Formulation Development >> Overview

The development of solid dosage forms is our specialty, with focus on complex formulations and vast expertise for multiparticulate systems. Our development and manufacturing centers with FDA and EU-GMP certification are well equipped for all your requirem

Contact

Clinical Test Samples

API/FDF Drug Development >> Formulation Development >> Clinical Supply

Glatt's facilities and quality-assured processes are GMP compliant manufacturer of placebo and verum for clinical studies in lab and on a pilot scale. Our services include the manufacture of clinical test samples for all solid dosage forms that can be imp

Contact

Development of Highly Active Pharmaceutical Ingredients (HAPI)

API/FDF Drug Development >> API Development >> High Potency APIs (HPAPIs)

Minakem High Potent site of Mont St Guibert has pioneered from the late 90’s the utilization of containment technology (closed systems) for the production of HAPIs.

Contact

Process Development

API/FDF Drug Development >> API Development >> Route Evaluation & Development

For more than 40 years, Pfizer have manufactured complex compounds for there biopharmaceutical partners, guiding their drugs safely from development through commercialization.

PharmaCompass >>

Filter By

Category

Sub Category See All

Capsule (14)

Otic (2)

Patch (2)

Tablet (15)

Country See All

Companies See All